Largest pharmaceuticals by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Veradermics has the lowest figure of the 61 pharmaceuticals ranked by total assets, at CHF 128.7M, followed by Erasca (CHF 334M) and Definium Therapeutics (CHF 371.1M). Figures as of 18 Nov 2026, 16:15 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsCHF 128.7M
- Median
- CHF 3B
- Combined market value
- CHF 4.28T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | CHF 128.7M | CHF 4.4B | CHF 104.94 | 0.94% down | 233% up | ||
| 2 | ErascaERAS · Health Care | CHF 334M | CHF 3.9B | CHF 11.15 | 4.82% down | 403% up | ||
| 3 | Definium TherapeuticsDFTX · Health Care | CHF 371.1M | CHF 3.3B | CHF 24.02 | 3.05% down | 169% up | ||
| 4 | Rhythm PharmaceuticalsRYTM · Health Care | CHF 404.9M | CHF 6.8B | CHF 98.40 | 0.08% up | 13% up | ||
| 5 | Oruka TherapeuticsORKA · Health Care | CHF 412M | CHF 5.5B | CHF 81.41 | 0.24% up | 241% up | ||
| 6 | Dianthus TherapeuticsDNTH · Health Care | CHF 447.7M | CHF 4.1B | CHF 72.83 | 0.69% down | 113% up | ||
| 7 | Edgewise TherapeuticsEWTX · Health Care | CHF 465.9M | CHF 3.8B | CHF 34.44 | 2.85% down | 88% up | ||
| 8 | Travere TherapeuticsTVTX · Health Care | CHF 510.3M | CHF 4.1B | CHF 42.38 | 1.64% down | 44% up | ||
| 9 | ABIVAXABVX · Health Care | CHF 546.7M | CHF 6.2B | CHF 70.46 | 1.79% up | 27% down | ||
| 10 | Protagonist TherapeuticsPTGX · Health Care | CHF 563.4M | CHF 6.9B | CHF 105.02 | 0.10% down | 46% up | ||
| 11 | Axsome TherapeuticsAXSM · Health Care | CHF 581.6M | CHF 5.9B | CHF 112.52 | 1.84% down | 7% down | ||
| 12 | Summit TherapeuticsSMMT · Health Care | CHF 633.4M | CHF 7.2B | CHF 9.03 | 0.33% up | 36% down | ||
| 13 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 643.9M | CHF 6.4B | CHF 81.03 | 1.04% up | 126% up | ||
| 14 | Spyre TherapeuticsSYRE · Health Care | CHF 655.8M | CHF 7.6B | CHF 80.26 | 1.47% up | 286% up | ||
| 15 | Belite BioBLTE · Health Care | CHF 658.1M | CHF 5.5B | CHF 134.20 | 0.91% up | 31% up | ||
| 16 | Corcept TherapeuticsCORT · Health Care | CHF 705.4M | CHF 6.3B | CHF 57.56 | 2.58% down | 8% down | ||
| 17 | Mirum PharmaceuticalsMIRM · Health Care | CHF 710.6M | CHF 5B | CHF 76.80 | 0.95% down | 31% up | ||
| 18 | BridgeBio PharmaBBIO · Health Care | CHF 789.2M | CHF 12.7B | CHF 65.42 | 1.03% up | 17% up | ||
| 19 | Cogent BiosciencesCOGT · Health Care | CHF 790.6M | CHF 4.2B | CHF 23.90 | 1.80% up | 20% down | ||
| 20 | Praxis Precision MedicinesPRAX · Health Care | CHF 790.8M | CHF 7.2B | CHF 256.91 | 0.12% down | 61% up | ||
| 21 | TG TherapeuticsTGTX · Health Care | CHF 896.5M | CHF 8.2B | CHF 54.42 | 2.93% up | 107% up | ||
| 22 | Madrigal PharmaceuticalsMDGL · Health Care | CHF 1.1B | CHF 8B | CHF 345.53 | 2.89% down | 24% down | ||
| 23 | Arrowhead PharmaceuticalsARWR · Health Care | CHF 1.2B | CHF 5.2B | CHF 36.51 | 0.72% up | 10% up | ||
| 24 | CytokineticsCYTK · Health Care | CHF 1.2B | CHF 6B | CHF 43.14 | 0.95% down | 20% down | ||
| 25 | Ascendis PharmaASND · Health Care | CHF 1.2B | CHF 14.9B | CHF 227.45 | 0.53% down | 28% up | ||
| 26 | Ligand PharmaceuticalsLGND · Health Care | CHF 1.3B | CHF 5B | CHF 252.43 | 1.90% up | 43% up | ||
| 27 | Legend BiotechLEGN · Health Care | CHF 1.5B | CHF 2.7B | CHF 13.69 | 0.81% up | 42% down | ||
| 28 | InsmedINSM · Health Care | CHF 1.9B | CHF 22.2B | CHF 101.19 | 1.52% down | 40% down | ||
| 29 | AlkermesALKS · Health Care | CHF 2.1B | CHF 6.6B | CHF 39.30 | 2.54% up | 58% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | CHF 2.4B | CHF 4.2B | CHF 50.86 | 0.07% down | 20% down | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | CHF 3B | CHF 3.8B | CHF 23.04 | 1.35% up | 64% down | ||
| 32 | Amneal PharmaceuticalsAMRX · Health Care | CHF 3.1B | CHF 6.3B | CHF 18.15 | 1.94% up | 83% up | ||
| 33 | Alnylam PharmaceuticalsALNY · Health Care | CHF 4.2B | CHF 17.3B | CHF 128.91 | 2.31% down | 66% down | ||
| 34 | Roivant SciencesROIV · Health Care | CHF 4.8B | CHF 23.7B | CHF 32.67 | 0.10% up | 90% up | ||
| 35 | Dr. Reddy's LaboratoriesRDY · Health Care | CHF 5.2B | CHF 10.5B | CHF 12.63 | 1.25% up | 5% up | ||
| 36 | BioMarin PharmaceuticalBMRN · Health Care | CHF 6.4B | CHF 9.8B | CHF 50.50 | 2.36% up | 11% up | ||
| 37 | United TherapeuticsUTHR · Health Care | CHF 6.6B | CHF 20.6B | CHF 484.05 | 1.72% down | 23% up | ||
| 38 | BeOne MedicinesONC · Health Care | CHF 6.9B | CHF 38.9B | CHF 340.26 | 2.35% down | 17% up | ||
| 39 | Jazz PharmaceuticalsJAZZ · Health Care | CHF 9.8B | CHF 13.2B | CHF 205.34 | 1.17% up | 37% up | ||
| 40 | GenmabGMAB · Health Care | CHF 10.9B | CHF 26.7B | CHF 43.28 | 1.21% down | 70% up | ||
| 41 | Elanco Animal HealthELAN · Health Care | CHF 11.3B | CHF 11.1B | CHF 22.23 | 2.01% up | 20% up | ||
| 42 | ZoetisZTS · Health Care | CHF 13B | CHF 28.7B | CHF 70.61 | 0.32% up | 29% down | ||
| 43 | Royalty PharmaRPRX · Health Care | CHF 16.5B | CHF 33.2B | CHF 57.71 | 0.35% down | 78% up | ||
| 44 | GrifolsGRFS · Health Care | CHF 18.4B | CHF 4.9B | CHF 7.20 | 1.10% down | 1% up | ||
| 45 | Vertex PharmaceuticalsVRTX · Health Care | CHF 21.6B | CHF 114.1B | CHF 449.90 | 0.12% down | 27% up | ||
| 46 | ViatrisVTRS · Health Care | CHF 31.4B | CHF 20B | CHF 17.42 | 1.00% up | 96% up | ||
| 47 | Regeneron PharmaceuticalsREGN · Health Care | CHF 34.2B | CHF 83.2B | CHF 804.68 | 0.36% down | 36% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | CHF 34.4B | CHF 41.6B | CHF 35.65 | 0.81% down | 74% up | ||
| 49 | Novo NordiskNVO · Health Care | CHF 67.9B | CHF 147.4B | CHF 33.44 | 2.56% down | 17% down | ||
| 50 | GSKGSK · Health Care | CHF 68.4B | CHF 82.4B | CHF 41.12 | 0.95% down | 6% up | ||
| 51 | Abbott LaboratoriesABT · Health Care | CHF 73.1B | CHF 152.1B | CHF 87.83 | 0.52% down | 17% down | ||
| 52 | Bristol-Myers SquibbBMY · Health Care | CHF 75.9B | CHF 103.3B | CHF 50.56 | 2.27% down | 34% up | ||
| 53 | Takeda PharmaceuticalTAK · Health Care | CHF 81.9B | CHF 57.5B | CHF 18.01 | 1.29% down | 54% up | ||
| 54 | NovartisNVS · Health Care | CHF 93.5B | CHF 248.6B | CHF 131.64 | 1.89% down | 25% up | ||
| 55 | Eli LillyLLY · Health Care | CHF 94.8B | CHF 1.04T | CHF 1,170.21 | 1.96% down | 35% up | ||
| 56 | AstraZenecaAZN · Health Care | CHF 96.2B | CHF 233.7B | CHF 150.67 | 1.96% down | 2% up | ||
| 57 | AbbVieABBV · Health Care | CHF 113B | CHF 429.6B | CHF 243.01 | 1.57% down | 26% up | ||
| 58 | Merck & CoMRK · Health Care | CHF 115.4B | CHF 289.9B | CHF 117.61 | 2.71% down | 51% up | ||
| 59 | SanofiSNY · Health Care | CHF 118.6B | CHF 95.8B | CHF 39.88 | 0.49% down | 4% down | ||
| 60 | Johnson & JohnsonJNJ · Health Care | CHF 168B | CHF 558.5B | CHF 231.99 | 1.28% down | 38% up | ||
| 61 | PfizerPFE · Health Care | CHF 175.5B | CHF 135.3B | CHF 23.74 | 1.12% down | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8432 CHF).
Questions and answers
Which pharmaceuticals have the lowest total assets?
Veradermics (CHF 128.7M), Erasca (CHF 334M) and Definium Therapeutics (CHF 371.1M) have the lowest total assets of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 16:15 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total assets have a combined market value of CHF 4.28T as of 18 Nov 2026, 16:15 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.